Cinacalcet for hypercalcemia after kidney transplantation with autonomous hyperparathyroidism

Phase 3, randomised, double-blind trial in hypercalcemia and hyperparathyroidism comparing Cinacalcet with Placebo (2 arms). Primary endpoint: Achievement of mean corrected total serum calcium below 10.2 mg/dL during the efficacy assessment phase. Started Jul 2009; status: terminated.